Publication | Closed Access

Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells

Anti-angiogenic ActivityAnaplastic Thyroid CarcinomaOncologyMedicinePathologyTumor TargetingAnti-cancer AgentCancer TreatmentPharmacologyVascular EndothelialTumor MicroenvironmentTumor Biology